Previous 10 | Next 10 |
After decades of federal prohibition prevented the research and medical use of psychedelic drugs, the U.S. Department of Veteran Affairs is now considering opening the door to psychedelic treatments for veterans. Research in the 1960s first revealed that psychedelics had therapeutic propert...
2023-03-05 15:00:00 ET Summary Mental health may be our biggest health issue and traditional medicine has had limited success in treating it. Psychedelic compounds have been healing people for thousands of years but there are challenges around how to properly service the public. ...
Ayahuasca is one of the several psychedelics that have exhibited significant potential as treatment for mental health disorders . Research has revealed that psychedelics such as ayahuasca are capable of alleviating the symptoms of conditions, including treatment-resistant depression and post-t...
Summary There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Despite a potential opportunity for disruption, investors should keenly understand the unique risks to biotechnology plays before investing in the space. Given...
A surge of psychedelic research over the past decade has revealed what some scientists in the late 1950s and early 19960s suspected: hallucinogens have protective mental health properties. Groundbreaking research in recent years has shown that classic psychedelics such as DMT, psilocybin, ketam...
At the start of the year, the Colorado Department of Regulatory Agencies (DORA) began searching for individuals to join an advisory board that would be responsible for informing on psychedelic policy. As part of those efforts, DORA promoted a web page where interested professionals could fill...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value. They’re also followi...
During a recent webinar , an official of the Department of Veterans Affairs revealed that the agency was closely observing psychedelics policy and research as the reform wave continued to sweep across states in the country. Dr. Ilse Wiechers, deputy executive director of the Office of Mental He...
Palm Beach, FL – January 26, 2023 – FinancialNewsMedia.com News Commentary – Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of these continually expanding markets. Psychedeli...
With at least one in five Americans said to experience mental illness at least once a year and more than 2.7 million youth suffering from severe major depression, interest in safe and effective mental health treatments is at an all-time high. Initial research has uncovered that psychedelics s...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...